Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study.

Ritsner M, Ponizovsky A, Endicott J, Nechamkin Y, Rauchverger B, Silver H, Modai I.

Eur Neuropsychopharmacol. 2002 Feb;12(1):31-8.

PMID:
11788238
2.

Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients.

Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, Goldin V, Ponizovsky A.

J Clin Psychiatry. 2000 Nov;61(11):880-9; quiz 890.

PMID:
11105747
3.

[The subjective quality of life of patients with schizophrenia: influence of psychopathology and patients' expectations. A comparative study].

Salomé F, Petitjean F, Germain C, Demant JC.

Encephale. 2004 Jan-Feb;30(1):60-8. French.

PMID:
15029078
4.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

5.

A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.

Awad AG, Voruganti LN, Heslegrave RJ.

Qual Life Res. 1997 Jan;6(1):21-6.

PMID:
9062438
6.

Satisfaction with quality of life varies with temperament types of patients with schizophrenia.

Ritsner M, Farkas H, Gibel A.

J Nerv Ment Dis. 2003 Oct;191(10):668-74.

PMID:
14555869
7.

Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.

Yen CF, Cheng CP, Huang CF, Yen JY, Ko CH, Chen CS.

Bipolar Disord. 2008 Jul;10(5):617-24. doi: 10.1111/j.1399-5618.2007.00577.x.

PMID:
18657246
8.

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.

Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):703-12. Epub 2007 Jan 16.

PMID:
17289237
9.

Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Lambert M, Naber D.

CNS Drugs. 2004;18 Suppl 2:5-17; discussion 41-3. Review.

PMID:
15461312
10.

Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.

Ritsner M, Perelroyzen G, Ilan H, Gibel A.

J Clin Psychopharmacol. 2004 Jun;24(3):245-54.

PMID:
15118477
11.

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW.

J Clin Psychiatry. 2004 Jul;65(7):932-9.

PMID:
15291682
12.

Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.

Wehmeier PM, Kluge M, Schacht A, Helsberg K, Schreiber W, Schimmelmann BG, Lambert M.

J Psychiatr Res. 2008 Jul;42(8):676-83. Epub 2007 Aug 27.

PMID:
17720192
14.

Predictors of quality of life in major psychoses: a naturalistic follow-up study.

Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y.

J Clin Psychiatry. 2003 Mar;64(3):308-15.

PMID:
12716273
15.

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW.

Arch Gen Psychiatry. 2006 Oct;63(10):1079-87.

PMID:
17015810
16.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Awad AG, Voruganti LN.

CNS Drugs. 2004;18(13):877-93. Review.

PMID:
15521791
17.

Predicting changes in domain-specific quality of life of schizophrenia patients.

Ritsner M.

J Nerv Ment Dis. 2003 May;191(5):287-94.

PMID:
12819547
18.

[Comparative evaluation of quality of life in patients with schizophrenia treated with conventional versus atypical neuroleptics: results of a transversal study].

Divanon F, Delamillieure P, Lehaguez A, Vasse T, Morello R, Gourevitch R, Langlois S, Assouly-Besse F, Guelfi JD, Petit M, Dollfus S.

Encephale. 2006 Jul-Aug;32(4 Pt 1):459-65. French.

PMID:
17099557
19.

The relationship between patient satisfaction and treatment outcomes in schizophrenia.

Chue P.

J Psychopharmacol. 2006 Nov;20(6 Suppl):38-56. Review.

PMID:
17046986
20.

Predictors of subjective and objective quality of life in outpatients with schizophrenia.

Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.

Psychiatry Clin Neurosci. 2008 Aug;62(4):404-11. doi: 10.1111/j.1440-1819.2008.01818.x.

Supplemental Content

Support Center